CRP and lung cancer: In a large Danish COPD population study, an elevated WBC count in combination with elevated levels of CRP and fibrinogen was associated with a two- to four-fold increased risk of major comorbidities such as ischemic heart disease, diabetes, lung cancer, and pneumonia [6].